SHANGHAI and CAMBRIDGE, Mass. and REYKJAVIK, Iceland, March 2, 2017 /PRNewswire/ -- WuXi NextCODE, the contract genomics organization enabling precision medicine worldwide, today announced its presentation at the upcoming 37th Annual Cowen and Company Healthcare Conference at 10am ET on Monday, March 6th, in Boston, MA.
WuXi NextCODE CEO Hannes Smarason will provide a full corporate overview and update on recent partnerships and milestones in the execution of the company's strategy to provide a fully integrated, global standard platform for using large-scale genomics data – to improve healthcare, medicine and wellness for people and populations around the world.
About WuXi NextCODE
WuXi NextCODE is a fully integrated global contract genomics organization. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer comprehensive services that enable population, precision medicine, diagnostics and wellness initiatives and enterprises to use the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi AppTec group company. Visit us on the web at wuxinextcode.com.
Edward Farmer, PhD
SOURCE WuXi NextCODE